PA
ADAP

Procyon Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Procyon Advisors’s Portfolio ADAP Stock Details ADAP Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,000
Closed -$20.5K – 519
2024
Q1 		$20.5K Buy
+13,000
New +$20.5K ﹤0.01% 508